KINDAI UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.kindai.ac.jp
Clinical Trials
48
Active:0
Completed:22
Trial Phases
4 Phases
Phase 1:1
Phase 2:2
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Not Applicable
40 (88.9%)Phase 2
2 (4.4%)Phase 4
2 (4.4%)Phase 1
1 (2.2%)PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
Phase 4
Recruiting
- Conditions
- ST-segment Elevation Myocardial Infarction (STEMI)
- Interventions
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Kindai University
- Target Recruit Count
- 2258
- Registration Number
- NCT05709626
- Locations
- 🇯🇵
Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan
Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Kindai University
- Target Recruit Count
- 51
- Registration Number
- NCT04761380
- Locations
- 🇯🇵
Kindai University Faculty of Medicine, Ōsaka-sayama, Osaka, Japan
Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan
Phase 4
Recruiting
- Conditions
- Metastatic Castration-sensitive Prostate Cancer
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Kindai University
- Target Recruit Count
- 100
- Registration Number
- NCT04601441
- Locations
- 🇯🇵
Kindai University Hospital, Ōsaka-sayama, Osaka, Japan
Pembrolizumab as Neoadjuvant Treatment in HCC
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- Kindai University
- Target Recruit Count
- 50
- Registration Number
- NCT03337841
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography
- Conditions
- Chronic Hepatitis BChronic Hepatitis C
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2011-05-26
- Lead Sponsor
- Kindai University
- Target Recruit Count
- 1000
- Registration Number
- NCT01360892
- Locations
- 🇯🇵
Kinki University Faculty of Medicine, Osaka-sayama, Osaka, Japan
- Prev
- 1
- 2
- Next
News
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
A Phase 2 trial of L-arginine in Spinocerebellar Ataxia type 6 (SCA6) showed a trend toward symptom improvement, but the results did not reach statistical significance.